Literature DB >> 3266982

Parameters of production and partial characterization of feline interleukin 2.

R M Bauer1, R G Olsen.   

Abstract

The conditions for the production of feline interleukin 2 (IL-2) from peripheral blood leukocytes (PBL) and splenocytes by concanavalin A (Con A) stimulation are described. Feline IL-2 was quantitated by measuring DNA synthesis in the murine IL-2-dependent cell line, CTLL-20. In addition, feline IL-2 was generated for the maintenance of long-term cultures of Con A-stimulated feline PBL and for biochemical characterization. Finally, IL-2 production was evaluated from the PBL of feline leukemia virus (FeLV)-infected cats. Con A at 9.6 micrograms/ml produced a plateau of peak IL-2 activity from 24 to 48 h following stimulation. The tumor promoter, phorbol myristic acetate, stimulated feline IL-2 production and enhanced Con A-stimulated feline IL-2 production. Fetal calf serum (FCS) was not required for IL-2 production; however, FCS at 5% (v/v) allowed for maximal Con A-stimulated IL-2 production. Feline IL-2 generated from Con A-stimulated splenocytes migrated with an apparent molecular size of 13.7 to 23 kD by gel filtration chromatography and supported the proliferation of Con A-activated feline PBL at a final concentration of 0.3 to 0.9 units/ml.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266982     DOI: 10.1016/0165-2427(88)90105-5

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  2 in total

1.  Development of monoclonal antibodies (MAbs) to feline interferon (fIFN)-γ as tools to evaluate cellular immune responses to feline infectious peritonitis virus (FIPV).

Authors:  Ryoichi Satoh; Ayumi Kaku; Megumi Satomura; Michiyo Kohori; Kanako Noura; Tomoko Furukawa; Masako Kotake; Tomomi Takano; Tsutomu Hohdatsu
Journal:  J Feline Med Surg       Date:  2011-02-22       Impact factor: 2.015

Review 2.  Feline immune system.

Authors:  D S Lin
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1992-01       Impact factor: 2.268

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.